Home Cart Sign in  
HazMat Fee +

There will be a HazMat fee per item when shipping a dangerous goods. The HazMat fee will be charged to your UPS/DHL/FedEx collect account or added to the invoice unless the package is shipped via Ground service. Ship by air in Excepted Quantity (each bottle), which is up to 1g/1mL for class 6.1 packing group I or II, and up to 25g/25ml for all other HazMat items.

Type HazMat fee for 500 gram (Estimated)
Excepted Quantity USD 0.00
Limited Quantity USD 15-60
Inaccessible (Haz class 6.1), Domestic USD 80+
Inaccessible (Haz class 6.1), International USD 150+
Accessible (Haz class 3, 4, 5 or 8), Domestic USD 100+
Accessible (Haz class 3, 4, 5 or 8), International USD 200+
Chemical Structure| 6151-25-3 Chemical Structure| 6151-25-3

Structure of Quercetin Dihydrate
CAS No.: 6151-25-3

Chemical Structure| 6151-25-3

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Quercetin dihydrate, a natural flavonoid, stimulates recombinant SIRT1 and inhibits PI3K with IC50 values of 2.4 μM, 3.0 μM, and 5.4 μM for PI3K γ, PI3K δ, and PI3K β, respectively.

Synonyms: Sophoretin

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

DE Stock

US Stock

Asia Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Quercetin Dihydrate

CAS No. :6151-25-3
Formula : C15H14O9
M.W : 338.27
SMILES Code : O=C1C(O)=C(C2=CC=C(O)C(O)=C2)OC3=C1C(O)=CC(O)=C3.[H]O[H].[H]O[H]
Synonyms :
Sophoretin
MDL No. :MFCD00149487
InChI Key :GMGIWEZSKCNYSW-UHFFFAOYSA-N
Pubchem ID :5284452

Safety of Quercetin Dihydrate

GHS Pictogram:
Signal Word:Danger
Hazard Statements:H301
Precautionary Statements:P264-P270-P301+P310+P330-P405-P501
Class:6.1
UN#:2811
Packing Group:

Related Pathways of Quercetin Dihydrate

PI3K-AKT

Isoform Comparison

Biological Activity

Target
  • p110γ

    PI3Kγ, IC50:2.4 μM

  • p110β

    PI3Kβ, IC50:5.4 μM

  • p110δ

    PI3Kδ, IC50:3.0 μM

  • SIRT1

In Vitro:

Cell Line
Concentration Treated Time Description References
Human Periodontal Ligament Cells (hPDLCs) 5 μM 24 h Quercetin at 5 μM strongly activated NRF2 signaling, alleviated oxidative damage and enhanced the antioxidant capacity of hPDLCs. Drug Des Devel Ther. 2021 Aug 12;15:3509-3522.
HK-2 human renal tubule epithelial cells 5 μM 48 h Quercetin significantly reduced the accumulation of fibrosis- and inflammation-related proteins induced by IL-33, improved renal cell pyroptosis, and acted through the IL-33/ST2 pathway. Antioxidants (Basel). 2022 Nov 13;11(11):2238.
HEK293 cells 10 μM To investigate the inhibitory effect of Quercetin on hP2X3 receptors, results showed that Quercetin inhibited hP2X3 with an IC50 of 4.72 ± 0.35 μM. Nat Commun. 2023 Sep 20;14(1):5844.
HEK293 cells 100 μM To investigate the inhibitory effect of Quercetin on hP2X1, hP2X4, and hP2X7 receptors, results showed that Quercetin inhibited hP2X1 by 21.4 ± 5.0%, with almost no inhibition of hP2X4 and hP2X7. Nat Commun. 2023 Sep 20;14(1):5844.
ER-α/ER-β reporter cells 0.023–50 µg/mL 24 h Quercetin had a small effect on ER-α but strongly activated ER-β, with an ER-β/ER-α specificity of 3.2. Int J Mol Sci. 2021 Jan 21;22(3):1032.
C2C12 skeletal muscle cells 25, 50, 75, 100 µM 24 h Quercetin significantly increased the viability of dexamethasone-treated C2C12 skeletal muscle cells and exerted antiapoptotic effects by regulating mitochondrial membrane potential (ΔΨm) and reducing oxidative species. Molecules. 2020 Jul 17;25(14):3267.
AMJ2-C11 cells 0, 5, 10, 20 μM 4 or 8 h To investigate the induction of HO-1 mRNA and protein expression by quercetin, results showed that quercetin dose-dependently induced HO-1 expression. Respir Res. 2014 Nov 21;15(1):150.
LA-4 cells 0, 5, 10, 20 μM 4 or 8 h To investigate the induction of HO-1 mRNA and protein expression by quercetin, results showed that quercetin dose-dependently induced HO-1 expression. Respir Res. 2014 Nov 21;15(1):150.
HBEC4 cells 0, 5, 10, 20 μM 4 or 8 h To investigate the induction of HO-1 mRNA and protein expression by quercetin, results showed that quercetin dose-dependently induced HO-1 expression. Respir Res. 2014 Nov 21;15(1):150.
MIN-6 cells 10 μM 1 h To investigate the effect of Quercetin on insulin secretion, results showed that 10 μM Quercetin significantly increased insulin secretion in the presence of 8.3 mmol/L glucose. Drug Des Devel Ther. 2018 Apr 23;12:955-966.
MIN-6 cells 10 μM 24 h To investigate the effect of Quercetin on palmitic acid-induced apoptosis in MIN-6 cells, results showed that 10 μM Quercetin significantly improved cell viability. Drug Des Devel Ther. 2018 Apr 23;12:955-966.

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
C57BL/6 mice Periodontitis model Oral gavage 50 mg/kg Once daily for 10 days Quercetin reduced oxidative stress levels and slowed alveolar bone absorption in periodontitis mice by activating the NRF2 signaling pathway. Drug Des Devel Ther. 2021 Aug 12;15:3509-3522.
MRL/lpr mice Systemic lupus erythematosus (SLE) model Oral gavage 40 mg/kg Once daily for three months Quercetin improved renal function and inhibited the expression of fibrosis- and inflammation-related markers in MRL/lpr mice. Antioxidants (Basel). 2022 Nov 13;11(11):2238.
Mice Sod1KO mice Oral gavage 50 mg/kg Three consecutive days every 15 days for 7 months To study the effect of D + Q on inflammation and hepatocellular carcinoma in the livers of Sod1KO mice. The results showed that D + Q significantly reduced markers of inflammation and the incidence of hepatocellular carcinoma in the livers of Sod1KO mice. Aging Cell. 2022 Aug;21(8):e13676
C57BL/6 mice Chronic cough model Oral 150 mg/kg Twice daily for 7 days To investigate the cough-relieving effect of Quercetin on chronic cough, results showed that 150 mg/kg Quercetin significantly reduced the frequency of coughing in mice. Nat Commun. 2023 Sep 20;14(1):5844.
Mice Triple-transgenic Alzheimer's disease model mice Oral 100 mg/kg Every 48 hours for one year To evaluate the effect of long-term oral administration of Quercetin on neurodegeneration markers and cognitive function in triple-transgenic Alzheimer's disease model mice. The results showed that Quercetin significantly reduced β-amyloid aggregation and partially reduced tau hyperphosphorylation, thereby improving cognitive function in mice. Molecules. 2019 Jun 20;24(12):2287
BALB/c mice LPS-induced acute lung injury model Intratracheal administration 10μM,50μl Single dose 6 hours before LPS challenge To investigate the protective effects of quercetin on LPS-induced acute lung injury, results showed that quercetin pretreatment significantly attenuated LPS-induced pulmonary edema and inflammation. Respir Res. 2014 Nov 21;15(1):150.
Db/db mice Type 2 diabetes model Intragastric administration 0.5 g/kg Once daily for 4 weeks To investigate the effect of Quercetin on glucose tolerance and insulin secretion in db/db mice, results showed that Quercetin significantly improved glucose tolerance and insulin secretion. Drug Des Devel Ther. 2018 Apr 23;12:955-966.

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT01881919 Hyperuricemia ... More >> Gout Kidney Calculi Diabetes Cardiovascular Disease Less << Early Phase 1 Completed - United Kingdom ... More >> School of Food Science and Nutrition Leeds, West Yorkshire, United Kingdom, LS2 9JT Less <<

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.96mL

0.59mL

0.30mL

14.78mL

2.96mL

1.48mL

29.56mL

5.91mL

2.96mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories